News
-
How Will Generative AI Change the Role of Clinicians In the Next 10 Years?
A new report predicted that generative AI tools will increasingly streamline many aspects of a clinician’s day in the next five to 10 years — and that this is particularly true for tools that can automate diagnoses and respond to patients’ questions.
-
Health IT, MedCity Influencers
Data Access and Equity: How Secure Engagement Data Sharing Makes for Healthier Patients
The fusion of clinical and engagement data can revolutionize the way we understand and treat patients. By optimizing data collection and synthesis, securely sharing data, and ensuring equitable access, we can make significant strides towards delivering more personalized, effective, and patient-centered care.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Amgen, FTC Settlement Allows $28B Horizon Acquisition to Move Forward
Amgen and the Federal Trade Commission are settling the lawsuit the regulator filed to block the pharmaceutical giant’s $28 billion Horizon Therapeutics acquisition. As part of the settlement, Amgen agrees not to “bundle” its products with Horizon’s drugs in negotiations with health plans.
-
Bicycle Health, Albertsons Form Partnership To Expand Access to OUD Treatment
Through a new partnership, Bicycle Health providers can prescribe patients buprenorphine extended release injections (otherwise known as Sublocade), which can be administered by a pharmacist at an Albertsons pharmacy.
-
What Do Value-Based Care Startups Need to Do to Attract Investors?
As the value-based care market gets more crowded, startups in this space will have to nail down the fundamentals in order to attract capital from investors, healthcare business expert Paul Campbell said during a virtual conference. He encouraged startups to be crystal clear about what their value proposition is for three main stakeholders — patients, providers and payers.
-
Senate Bill Proposes Slashing ‘Red Tape’ Around Biosimilar Interchangeability
Legislation introduced by Utah Senator Mike Lee would eliminate testing to show a biosimilar can be substituted for a reference biologic product. Lee contends the current testing requirement adds costs and delays market access for these lower-cost biological medicines.
-
Developing Nursing Clinical Judgment Competency Through Virtual Reality
When real-life failure is not an option, practicing curated, trial-and-error simulations in VR can reduce patient risk in high-acuity scenarios. With nursing faculty also in short supply and a wave rapidly approaching retirement age, virtual reality simulations can help bridge the gap between learners needing supervised clinical experiences, and time-pressed preceptors, who have their own patients to care for in addition to guiding novices in clinical settings.
-
Intermountain’s Value-based Subsidiary Selects Headspace for Mental Health Support
Through a new partnership, Castell will be able to refer members of its Utah health plan customers to Headspace for behavioral health coaching and therapy.
-
Health IT Firms Could Be Fined Up to $1M for Info Blocking Starting 9/1
Beginning September 1, HHS’ Office of the Inspector General will begin enforcing the anti-information blocking regulations laid out in the 21st Century Cures Act. EHR vendors are the entities that are most at risk of being fined — they could face penalties up to $1 million.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Two Chairs Unveils Group Therapy, Care Navigation Offerings
Mental health company Two Chairs launched two new solutions Tuesday: group therapy and care navigation. The offerings will help improve access to mental health care and lead to better clinical outcomes, said Alex Katz, CEO and founder of the company
-
Debunking Healthcare’s Recession-Proof Reputation
During past recessions, the healthcare sector remained relatively immune to economic downswings — but things are different now that a sweeping labor shortage and lower patient volumes have been added to the mix.
-
What Impact Will California’s New “Transaction Review” Law Have?
California passed a law last year aimed at controlling rising healthcare costs that gave the state the ability to scrutinize healthcare deals of a certain size involving California companies. What impact can it have?
-
Still Hungry for New Obesity Meds, Novo Nordisk Makes Another M&A Deal
Novo Nordisk is expanding its cardiometabolic drug pipeline with the acquisition of Embark Biotech, a startup developing drugs for a novel target that can suppress appetite and boost calorie burning in cells. Embark’s science comes University of Copenhagen research on a novel fat cell target.
-
MedCity Influencers, Health Tech, Payers
Streamlining Healthcare Insurers’ Processes: Unlocking Efficiency and Collaboration for Enhanced Outcomes
While the recent rollbacks of authorization requirements by insurers are a positive step forward, there is still work to be done in streamlining processes and reducing administrative burdens in the healthcare industry.
-
Strive Health, Oak Street Health Strike Kidney Care Partnership
Kidney care company Strive Health announced last week that it is collaborating with primary care company Oak Street Health to serve Medicare members with stage 4 chronic kidney disease and end-stage kidney disease.
-
MedCity Influencers, BioPharma
The Inflation Reduction Act’s Impact on Drug Development for Rare Diseases
Despite these wins for many patients, the new law is already impacting the discovery and development of new drugs for people living with orphan diseases. Not only are drugs that could treat more than one disease being disincentivized, small molecule medicines, which play an important role in treating neurological disorders, cancers, and other diseases, may also be disadvantaged by the law.
-
MedCity Influencers, Health Tech
5 Ways NLP AI Technology is Driving Value for Providers Today
Don’t bet so big on AI solutions with “someday potential” that you ignore tools that can solve challenges and generate ROI now. Here are five critical AI investments that provide “right now” value for health systems, clinicians and patients.
-
Apellis Lays Off 25% of Staff and Turns Focus to Commercializing New Eye Drug
The Apellis Pharmaceuticals restructuring will save up to $300 million. It comes as the biotech continues its inquiry into the cause of a rare inflammatory complication reported in a small number of patients who received its geographic atrophy drug, Syfovre.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
